Morgan Stanley Put 60 NDA 20.09.2.../ DE000MG2V1R1 /
21/06/2024 18:35:37 | Var.- | Denaro08:03:17 | Lettera08:03:17 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.550EUR | - | 0.530 Quantità in denaro: 500 |
0.890 Quantità in lettera: 500 |
AURUBIS AG | 60.00 EUR | 20/09/2024 | Put |
GlobeNewswire
08:00
First gene therapy for prevalent pathologies in neurology receives FDA IND clearance - EG 427 initi...
GlobeNewswire
07:30
PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for u...
GlobeNewswire
07:30
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire
07:00
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®
GlobeNewswire
06:20
China's Hangzhou empowers urban development with world-class power supply reliability
GlobeNewswire
03:00
SALESFORCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Salesforce, Inc. on Behalf of Salesfo...
GlobeNewswire
03:00
NIKE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against...